Logos Global Management »

Argenx Se shares owned by Logos Global Management

Quarter-by-quarter ownership of Argenx Se (ARGX) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Argenx Se

Tip: Access up to 7 years of quarterly data

All positions including Argenx Se held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Argenx Se by Logos Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $55M 145k 380.43

More positions owned by Logos Global Management

Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Sarepta Therapeutics Call Option (SRPT)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Olema Pharmaceuticals (OLMA)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Rayzebio
Ambrx Biopharma
Karuna Therapeutics Ord
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Morphosys Sponsored Ads Call Option (MOR)

View all positions for Logos Global Management

Top funds holding Argenx Se

T. Rowe Price Associates
Artisan Partners Limited Partnership
Henderson Group
venBio Select Advisor
Bellevue Group
Massachusetts Financial Services
Holocene Advisors
Millennium Management
ClearBridge Advisors
Paradigm Biocapital Advisors
Federated Investors
Citadel Advisors
EcoR1 Capital
Bamco
Wellington Management Company

View all funds holding Argenx Se